Document Detail

Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials.
MedLine Citation:
PMID:  20811398     Owner:  NLM     Status:  In-Data-Review    
The oral assumption of lactotripeptides Valine-Proline-Proline (VPP) and Isoleucine-Proline-Proline (IPP) as nutraceuticals or functional foods is supposed to improve blood pressure (BP) control by angiotensin-converting enzyme-inhibition. However, data derived from clinical trials have reached conflicting conclusions. To perform a meta-analysis of placebo-controlled clinical trials evaluating the anti-hypertensive effect of lactotripeptides assumed as nutraceuticals or functional foods. Trials identified using a defined search strategy in PubMed were included in the meta-analysis, and their pooled effect was estimated with a random effects model, weighting for the inverse of the variance. Heterogeneity, publication bias, subgroup and meta-regression analyses were performed. A total of 18 trials have been identified, the clinical data of which have been clearly reported. Pooled effect of peptides was a reduction of -3.73 mm Hg (95% CI: -6.70, -1.76) for systolic blood pressure (SBP) and 1.97 mm Hg (95% CI: -3.85, -0.64) for diastolic blood pressure (DBP). The effect was more evident in Asian patients (SBP=-6.93 mm Hg (95% CI: -10.95, -2.94); DBP=-3.98 mm Hg(95% CI: -5.38, -2.44)) than in Caucasian ones (SBP=-1.17 mm Hg (95% CI: -2.82, 0.72); DBP=-0.52 mm Hg (95% CI: -1.39, 0.13)), and apparently not related to age, baseline BP values, dose of lactotripeptides assumed or length of the treatment. VPP and IPP lactotripeptides assumed as functional foods may significantly reduce SBP particularly in Asian subjects. The relevance of this findings in other ethnicities or associated with different dietary pattern should to be further investigated.
A F G Cicero; B Gerocarni; L Laghi; C Borghi
Related Documents :
19664528 - Effects of inhalational bronchodilator treatment during noninvasive ventilation in seve...
19205908 - Haemodynamic changes during craniotomy monitored by a bioimpedance plethysmographic non...
19851298 - Oral l-citrulline supplementation attenuates blood pressure response to cold pressor te...
11455998 - Blood pressure levels in xavánte adults from the pimentel barbosa indian reservation, ...
23799908 - Ultimate-shf trial (udenafil therapy to improve symptomatology, exercise tolerance and ...
11599678 - Recovery times and evaluation of clinical hemodynamic parameters of sevoflurane, isoflu...
Publication Detail:
Type:  Journal Article     Date:  2010-09-02
Journal Detail:
Title:  Journal of human hypertension     Volume:  25     ISSN:  1476-5527     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  425-36     Citation Subset:  IM    
Internal Medicine, Aging and Kidney diseases Department, Sant'Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
Next Document:  JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.